Amgen Patents for Cholesterol Drug Repatha Upheld by Jury

(Bloomberg) -- A U.S. jury upheld two patents for Amgen Inc.’s cholesterol-lowering drug Repatha, dealing a blow to Sanofi and Regeneron Pharmaceuticals Inc., which make a similar medication called...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.